All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Yi-Bin Chen discusses vedolizumab plus standard of care for GvHD prophylaxis at ASH 2018
Vedolizumab plus standard of care for GvHD prophylaxis
Highlights from the 1st EBMT GvHD Summit 2019
The 1st EBMT GvHD Summit took place in Warsaw from 16–18 May 2019. The aim of the Congress was to present the latest scientific development in biology, prophylaxis, and treatment of GvHD
ASH 2018 | Vedolizumab plus standard of care to prevent graft-versus-host disease – a phase Ib study
At ASH 2018, Doctor Chen presented the 6‑month results of a phase Ib study evaluating the safety, efficacy, and tolerability of vedolizumab in...
Subscribe to get the best content related to GvHD delivered to your inbox